Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01764282
Other study ID # 2012ZX10001007-001
Secondary ID
Status Completed
Phase N/A
First received December 26, 2012
Last updated August 24, 2017
Start date January 1, 2012
Est. completion date December 31, 2015

Study information

Verified date August 2017
Source National Center for AIDS/STD Control and Prevention, China CDC
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the effectiveness of reducing HIV transmission among sero-discordant couples by applying comprehensive intervention components.


Description:

A cluster-randomized controlled trial was carried out in forty counties from 16 cities. The strategy of Social Marketing was applied to influence sero-discordant couples' behavioral changes including safer sexual intercourses, regular HIV testing for the negative partners, antiretroviral therapy initiation.


Recruitment information / eligibility

Status Completed
Enrollment 11096
Est. completion date December 31, 2015
Est. primary completion date December 31, 2015
Accepts healthy volunteers No
Gender All
Age group 18 Years to 59 Years
Eligibility Inclusion Criteria:

- Couples are required to have a stable relationship and live together in the last 3 months;

- Older than 18 years and younger than 60 years; without regard to CD4 count;

- Open cohort(any newly diagnosed serodiscordant couples who are eligible for treatment will be included during the study period).

Exclusion Criteria:

- Couples are not have a stable relationship or do not live together in the last 3 months;

- Younger than 18 years old.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
comprehensive intervention components
ART promotion, Couple testing and consulting promotion, and Condom use promotion

Locations

Country Name City State
China Center for Disease Control and Prevention, Yunnan Province Kunming, Dehong, Wenshan, Honghe Yunnan
China Center for Disease Control and Prevention, Sichuan Province Liangshan Sichuan
China Center for Disease Control and Prevention,Guangxi Zhuang Autonomous Region Nanning, Guilin, Laibin, Qinzhou Guangxi
China Center for Disease Control and Prevention, Xinjiang Uygur Autonomous Region Urumchi, Ili Xinjiang
China Center for Disease Control and Prevention, Henan Province Zhumadian Henan

Sponsors (1)

Lead Sponsor Collaborator
National Center for AIDS/STD Control and Prevention, China CDC

Country where clinical trial is conducted

China, 

References & Publications (4)

Cohen MS, Gay CL. Treatment to prevent transmission of HIV-1. Clin Infect Dis. 2010 May 15;50 Suppl 3:S85-95. doi: 10.1086/651478. Review. — View Citation

He N, Duan S, Ding Y, Rou K, McGoogan JM, Jia M, Yang Y, Wang J, Montaner JS, Wu Z; China National HIV Prevention Study Group. Antiretroviral therapy reduces HIV transmission in discordant couples in rural Yunnan, China. PLoS One. 2013 Nov 13;8(11):e77981 — View Citation

Stephenson R, Barker J, Cramer R, Hall MA, Karita E, Chomba E, Vwalika C, Allen S. The demographic profile of sero-discordant couples enrolled in clinical research in Rwanda and Zambia. AIDS Care. 2008 Mar;20(3):395-405. doi: 10.1080/09540120701593497. — View Citation

Zhang F, Dou Z, Ma Y, Zhang Y, Zhao Y, Zhao D, Zhou S, Bulterys M, Zhu H, Chen RY. Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study. Lancet I — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary HIV seroconversion rate of HIV negatives among HIV serodiscordant couples up to 2 years
Secondary Proportion of HIV positives receiving ART among HIV serodiscordant couples up to 2 years
Secondary The incidence rate of AIDS-related diseases of HIV positives among serodiscordant couples up to 2 years
See also
  Status Clinical Trial Phase
Recruiting NCT06162897 - Case Management Dyad N/A
Completed NCT03999411 - Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients Phase 4
Completed NCT02528773 - Efficacy of ART to Interrupt HIV Transmission Networks
Active, not recruiting NCT05454839 - Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
Recruiting NCT05322629 - Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women N/A
Completed NCT02579135 - Reducing HIV Risk Among Adolescents: Evaluating Project HEART N/A
Active, not recruiting NCT01790373 - Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence N/A
Not yet recruiting NCT06044792 - The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
Completed NCT04039217 - Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM Phase 4
Active, not recruiting NCT04519970 - Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK) N/A
Completed NCT04124536 - Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women N/A
Recruiting NCT05599581 - Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health N/A
Active, not recruiting NCT04588883 - Strengthening Families Living With HIV in Kenya N/A
Completed NCT02758093 - Speed of Processing Training in Adults With HIV N/A
Completed NCT02500446 - Dolutegravir Impact on Residual Replication Phase 4
Completed NCT03805451 - Life Steps for PrEP for Youth N/A
Active, not recruiting NCT03902431 - Translating the ABCS Into HIV Care N/A
Completed NCT00729391 - Women-Focused HIV Prevention in the Western Cape Phase 2/Phase 3
Recruiting NCT05736588 - Elimisha HPV (Human Papillomavirus) N/A
Recruiting NCT03589040 - Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant Phase 2